Could this 20-minute test be the future of prostate cancer diagnosis? Experts weigh in
- Replies 1
Prostate cancer detection has long been a challenge, with lengthy tests and complex procedures often standing in the way of early diagnosis.
However, recent developments are bringing new hope to both doctors and patients alike.
What could be a game-changer in the fight against this common cancer is now making waves in the medical world.
An innovative 20-minute ultrasound test has the potential to dramatically reduce waiting times for prostate cancer detection, scientists revealed.
Developed by researchers at Heriot-Watt University in Edinburgh, the new technique could replace the traditional method of lengthy blood tests and MRI scans.
The test uses a dye with microbubbles injected into a vein, which travels to the prostate.
A high-resolution ultrasound then detects changes in blood flow, revealing the presence of cancerous tumours.
Early clinical trials at Western General Hospital in Edinburgh showed the test could detect up to 94 per cent of prostate tumours.
This method is also significantly cheaper than MRI scanning, costing only a tenth of the price.
In addition to faster detection, the test improves the accuracy of prostate biopsies and could enable more targeted therapies to destroy cancer cells.
The traditional prostate-specific antigen (PSA) blood test has proven unreliable, often leading to unnecessary, expensive MRI scans.
Dr George Papageorgiou, chief executive of Less Grey Imaging, the company behind the test, stated that the new method could ‘reliably detect clinically significant prostate cancer.’
He continued: ‘Currently, prostate cancer diagnosis varies widely across the country, with many patients being diagnosed too late for curative treatment.
'By integrating ultrasound more prominently into the diagnostic pathway, we can ensure early diagnosis.
'Urologists will have an imaging tool that enables accurate diagnoses and quicker decision-making.’
The technology’s promise has earned it a £370,000 grant from Innovate UK, the government group supporting innovation.
Professor Alan McNeill, a urological surgeon at the Western General and trustee of Prostate Scotland, explained: ‘This is the most common cancer in men but, if it is caught early while the cancer remains within the prostate, it can be cured in the majority of cases.’
Gary Tait, chairman of the Edinburgh & Lothian Prostate Cancer Support Group, expressed full support for the test, saying: ‘We fully support the development of this new technology which raises the possibility of enabling more men to be both diagnosed and treated earlier than at present.’
Around 3,400 men in Scotland are diagnosed with prostate cancer annually, highlighting the urgent need for faster, more effective detection methods.
If the test continues to show positive results in further trials, it could revolutionise the way prostate cancer is diagnosed, leading to quicker treatments and better outcomes for patients.
Could this new test be the breakthrough we’ve been waiting for in early cancer detection? We’d love to hear your thoughts – drop a comment below.
However, recent developments are bringing new hope to both doctors and patients alike.
What could be a game-changer in the fight against this common cancer is now making waves in the medical world.
An innovative 20-minute ultrasound test has the potential to dramatically reduce waiting times for prostate cancer detection, scientists revealed.
Developed by researchers at Heriot-Watt University in Edinburgh, the new technique could replace the traditional method of lengthy blood tests and MRI scans.
The test uses a dye with microbubbles injected into a vein, which travels to the prostate.
A high-resolution ultrasound then detects changes in blood flow, revealing the presence of cancerous tumours.
Early clinical trials at Western General Hospital in Edinburgh showed the test could detect up to 94 per cent of prostate tumours.
This method is also significantly cheaper than MRI scanning, costing only a tenth of the price.
In addition to faster detection, the test improves the accuracy of prostate biopsies and could enable more targeted therapies to destroy cancer cells.
The traditional prostate-specific antigen (PSA) blood test has proven unreliable, often leading to unnecessary, expensive MRI scans.
Dr George Papageorgiou, chief executive of Less Grey Imaging, the company behind the test, stated that the new method could ‘reliably detect clinically significant prostate cancer.’
He continued: ‘Currently, prostate cancer diagnosis varies widely across the country, with many patients being diagnosed too late for curative treatment.
'By integrating ultrasound more prominently into the diagnostic pathway, we can ensure early diagnosis.
'Urologists will have an imaging tool that enables accurate diagnoses and quicker decision-making.’
The technology’s promise has earned it a £370,000 grant from Innovate UK, the government group supporting innovation.
Professor Alan McNeill, a urological surgeon at the Western General and trustee of Prostate Scotland, explained: ‘This is the most common cancer in men but, if it is caught early while the cancer remains within the prostate, it can be cured in the majority of cases.’
Gary Tait, chairman of the Edinburgh & Lothian Prostate Cancer Support Group, expressed full support for the test, saying: ‘We fully support the development of this new technology which raises the possibility of enabling more men to be both diagnosed and treated earlier than at present.’
Around 3,400 men in Scotland are diagnosed with prostate cancer annually, highlighting the urgent need for faster, more effective detection methods.
If the test continues to show positive results in further trials, it could revolutionise the way prostate cancer is diagnosed, leading to quicker treatments and better outcomes for patients.
Could this new test be the breakthrough we’ve been waiting for in early cancer detection? We’d love to hear your thoughts – drop a comment below.
